Serial #98811655
LIVE

Serial Number

98811655

Owner

Ionis Pharmaceuticals, Inc.

Attorney

Brian Focarino

Filing Date

Oct 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98811655 Trademark

Serial Number: 98811655

Serial #98811655 is a trademark filed by Ionis Pharmaceuticals, Inc. on October 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ionis Pharmaceuticals, Inc. (8 trademarks)

2855 Gazelle Court
Carlsbad, CA 92010

Entity Type: 03

Trademark Details

Filing Date

October 21, 2024

Registration Date

Not Registered

Published for Opposition

May 27, 2025

Goods & Services

Medical services; medical information services; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; medical consulting services in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune lymphoproliferative, and rare diseases and disorders, and collecting data and information on autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders

Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceuticals for the treatment of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2026 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 30, 2025 EXRA
SOU EXTENSION 1 GRANTED
Sep 29, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 29, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 29, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 22, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 23, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 22, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2025 NWOS
NEW APPLICATION ENTERED
Oct 21, 2024 NWAP